In vitro analysis regarding the safety of components used in a film-based therapeutic system loaded with meglumine antimoniate and its activity toward Leishmania major experimental infections: a preliminary study

References

• Kshirsagar NA. Drug delivery systems. Indian J Pharmacol 2000;32:S54–S61
   Google Scholar
• Sáez V, Hernáez E, López L. Liberación controlada de fármacos: aplicaciones biomédicas. Rev Iberoam Polímeros 2003;4:112–22
   Google Scholar
• Sáez V, Hernáez E, Sanz L. Mecanismos de liberación de fármacos desde materiales polímeros. [Release mechanisms for drugs on the basis of polymer materials] Rev Iberoam Polímeros 2004;5:55–70
   Google Scholar
• Allevato MA. Sistemas terapeúticos transdermicos. [Transdermic therapeutic systems] Act Terap Dermatol 2007;30:154–65
   Google Scholar
• Ríos M, Cepero J. Citotoxicidad in vitro: sistema para la evaluación de biomateriales y equipos médicos implantables en Cuba. Rev CENIC Cienc Biológicas 2006;37:173–6
   Google Scholar
• Charlier CJ, Plomteux GJ. Immunotoxicity of drugs. J Pharm Belg 1997;52:196–200
   PubMedGoogle Scholar
• Dansette PM, Bonierbale E, Minoletti C, et al. Drug-induced immunotoxicity. Eur J Drug Metab Pharmacokinet 1998;23:443–51
   PubMed Web of Science ®Google Scholar
• González U, Pinart M, Rengifo-Pardo M, et al. Interventions for American cutaneous and mucocutaneous leishmaniasis. Cochrane Database Syst Rev 2009;CD004834:1–148
   Google Scholar
• TDR. Report of the scientific working group meeting on leishmaniasis. Genova: Tropical Disease Research – World Health Organization; 2004
   Google Scholar
• WHO. Control of the leishmaniasis. Technical report series, no. 949. Geneva; 2010. XII P
   Google Scholar
• Sebbag R. Situación de la leishmaniasis a nivel mundial y la contribución de Sanofi a través de su programa de acceso a medicamentos. Biomedica 2011;31:229
   Google Scholar
• Velez ID. Nuevos esquemas terapéuticos de la Organización Mundial de la Salud para el tratamiento de la leishmaniasis. Biomédica 2011;31:229
   Google Scholar
• Harris RE, Quitosano, un biopolímero con aplicaciones en sistemas de liberación controlada de fármacos. Facultad de Ciencias Biológicas-Departamento de Bioquímica y Biología Molecular I. Madrid: Universidad Complutense de Madrid; 2010:1–174
   Google Scholar
• Kumar MN, Muzzarelli RA, Muzzarelli C, et al. Chitosan chemistry and pharmaceutical perspectives. Chem Rev 2004;104:6017–84
   PubMed Web of Science ®Google Scholar
• Wang JJ, Zeng ZW, Xiao RZ, et al. Recent advances of chitosan nanoparticles as drug carriers. Int J Nanomedicine 2011;6:765–74
   PubMed Web of Science ®Google Scholar
• Luciano N, Helbling I, Luna J. Recent advances in chitosan films for controlled release of drugs. Recent Pat Drug Deliv Formul 2011;6:156–70
   Google Scholar
• Hemant KSY, Shivakumar HG. A comparative study of N-trimethyl chitosan chloride and chitosan microparticles as novel carriers for the delivery of hypertensive drug. J Pharm Res 2010;3:809–13
   Google Scholar
• Agnihotri SA, Mallikarjuna NN, Aminabhavi TM. Recent advances on chitosan-based micro- and nanoparticles in drug delivery. J Control Release 2004;100:5–28
   PubMed Web of Science ®Google Scholar
• Aranaz I, Mengíbar M, Harris R, et al. Functional characterization of chitin and chitosan. Curr Chem Biol 2009;3:203–30
   Google Scholar
• Jayakumar R, Prabaharan M, Sudheesh PT, et al. Biomaterials based on chitin and chitosan in wound dressing applications. Biotechnol Adv 2011;29:322–37
   PubMed Web of Science ®Google Scholar
• Bottomley KMK, Bradshaw D, Nixon JS. Metalloproteinases as targets for antiinflammatory drugs. Basel, Boston: Birkhäuser Verlag; 1999:145–61
   Google Scholar
• Willoughby DA, Tomlinson A. Inducible enzymes in the inflammatory response. Basel, Boston: Birkhäuser Verlag; 1999:1–30
   Google Scholar
• Folttmann H, Quadir A. Polyvinylpyrrolidone (PVP) – one of the most widely used excipients in pharmaceuticals: an overview. Drug Deliv Technol 2008;8:22–7. Available from: http://www.pharma-ingredients.basf.com/Documents/ENP/Review%20Articles/DDT-June-2008.pdf [last accessed July 2012]
   Google Scholar
• INS. Guía para la atención clínica integral del paciente con Leishmaniasis [Guide for a wholistic clinical approach to patients with leishmaniasis]; 2010
   Google Scholar
• Sánchez-Suárez JF. Efecto leishmanicida e inmunomodulador in vitro de extractos y compuestos de plantas colombianas de la familia Lauraceae y Rutaceae [In vitro leishmaniasis and immunomodulator effect of extracts and compounds of Colombian plants in the Lauraceae and Rutaceae family]. Bogotá: Universidad Nacional de Colombia, Facultad de Medicina; 2011:1--75
   Google Scholar
• American Society for Testing and Materials. Standard practice for direct contact cell culture evaluation of materials for medical devices. ASTM F 813--07 (2012)
   Google Scholar
• Escobar LM, Aristizabal F. Estudio comparativo de los métodos de resazurina y MTT en estudios de citotoxicidad en líneas célulares tumorales humanas. Vitae 2010;17:67–74
   Google Scholar
• Sánchez-Suárez J, Coy-Barrera E, Cuca LE, Delgado G. Leishmanicidal and cytotoxic activities of extracts and naturally-occurring compounds from two lauraceae species. Nat Prod Commun 2011;6:231–4
   PubMed Web of Science ®Google Scholar
• Pérez-Cordero JJ, Sánchez-Suárez J, Delgado G. Use of a fluorescent stain for evaluating in vitro infection with Leishmania panamensis. Exp Parasitol 2011;129:31–5
   PubMed Web of Science ®Google Scholar
• David CV, Craft N. Cutaneous and mucocutaneous leishmaniasis. Dermatol Ther 2009;22:491–502
   PubMed Web of Science ®Google Scholar
• Myler P, Fasel N. Leishmaniasis: after the genome. Norfolk (UK): Caister Academic Press; 2008
   Google Scholar
• Bogdan M. Leishmania–host-cell interaction: complexities and alternative views. Parasitol Today 2000;16:297–7
   Google Scholar
• Pujals G, Suñé-Negre JM, Pérez P, et al. In vitro evaluation of the effectiveness and cytotoxicity of meglumine antimoniate microspheres produced by spray drying against Leishmania infantum. Parasitol Res 2008;102:1243–7
   PubMed Web of Science ®Google Scholar
• Pearson RD, Wheeler DA, Harrison LH, Kay HD. The immunobiology of leishmaniasis. Rev Infect Dis 1983;5:907–27
   PubMedGoogle Scholar
• Schwartzman JD, Pearson RD. The interaction of Leishmania donovani promastigotes and human fibroblasts in vitro. Am J Trop Med Hyg 1985;34:850–5
   PubMed Web of Science ®Google Scholar
• Leal L, Perdomo S, Spinel C. Aislamiento y cultivo de fibroblastos endoneuronales. Acta Biol Colomb 2004;9:57--65
   Google Scholar
• Milon G, Del Giudice G, Louis JA. Immunobiology of experimental cutaneous leishmaniasis. Parasitol Today 1995;11:244–7
   PubMedGoogle Scholar
• Tanjak P, Ngamviriyavong P, Janvikul W. Antibacterial activity and cytotoxicity of chitosan and quaternized chitosans. Pure and Applied Chemistry International Conference 2011 (PACCON 2011); 2011; Srinakharinwirot University, Bangkok, Thailand
   Google Scholar
• Peluso G, Petillo O, Ranieri M, et al. Chitosan-mediated stimulation of macrophage function. Biomaterials 1994;15:1215–20
   PubMed Web of Science ®Google Scholar
• Ueno H, Nakamura F, Murakami M, et al. Evaluation efects of chitosan for the extracellular matrix production by fibroblasts and the growth factors production by macrophages. Biomaterials 2001;22:2125–30
   PubMed Web of Science ®Google Scholar
• Rennekampff HO, Hansbrough JF, Kiessig V, et al. Bioactive interleukin-8 is expressed in wounds and enhances wound healing. J Surg Res 2000;93:41–54
   PubMed Web of Science ®Google Scholar
• Nishimura K, Nishimura S, Nishi N, et al. Immunological activity of chitin and its derivatives. Vaccine 1984;2:93–9
   PubMedGoogle Scholar
• Delgado G, Sánchez Y, Plaza D, et al. An experimental approach to studying the effectiveness and safety of meglumine antimoniate formulations. Biomed Pharmacother 2011;65:569–77
   PubMed Web of Science ®Google Scholar
• Berenbaum MC. Synergy, additivism and antagonism in immunosuppression. A critical review. Clin Exp Immunol 1977;28:1–18
   PubMed Web of Science ®Google Scholar